More about
Systemic And Local Inflammation
News
September 25, 2024
1 min read
Save
Rocatinlimab exhibits positive results in phase 3 study for atopic dermatitis
Rocatinlimab exhibited promising results in the phase 3 ROCKET HORIZON trial for the treatment of moderate to severe atopic dermatitis, Kyowa Kirin announced in a press release.